HomeCompareBDX vs DRI

BDX vs DRI: Dividend Comparison 2026

BDX yields 2.27% · DRI yields 3.02%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DRI wins by $432.32M in total portfolio value
10 years
BDX
BDX
● Live price
2.27%
Share price
$154.69
Annual div
$3.51
5Y div CAGR
13.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.9K
Annual income
$1,058.14
Full BDX calculator →
DRI
DRI
● Live price
3.02%
Share price
$195.05
Annual div
$5.90
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$432.34M
Annual income
$406,525,727.38
Full DRI calculator →

Portfolio growth — BDX vs DRI

📍 DRI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBDXDRI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BDX + DRI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BDX pays
DRI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BDX
Annual income on $10K today (after 15% tax)
$192.91/yr
After 10yr DRIP, annual income (after tax)
$899.42/yr
DRI
Annual income on $10K today (after 15% tax)
$257.11/yr
After 10yr DRIP, annual income (after tax)
$345,546,868.27/yr
At 15% tax rate, DRI beats the other by $345,545,968.85/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BDX + DRI for your $10,000?

BDX: 50%DRI: 50%
100% DRI50/50100% BDX
Portfolio after 10yr
$216.19M
Annual income
$203,263,392.76/yr
Blended yield
94.02%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on DRI right now

BDX
Analyst Ratings
16
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$193.80
+25.3% upside vs current
Range: $170.00 — $215.00
Altman Z
2.1
Piotroski
8/9
DRI
Analyst Ratings
38
Buy
20
Hold
1
Sell
Consensus: Buy
Price Target
$225.33
+15.5% upside vs current
Range: $200.00 — $265.00
Altman Z
2.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BDX buys
0
DRI buys
0
No recent congressional trades found for BDX or DRI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBDXDRI
Forward yield2.27%3.02%
Annual dividend / share$3.51$5.90
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR13.5%100%
Portfolio after 10y$26.9K$432.34M
Annual income after 10y$1,058.14$406,525,727.38
Total dividends collected$5.7K$430.43M
Payment frequencyquarterlyquarterly
SectorHealthcareConsumer Discretionary
Analyst consensusBuyBuy
Analyst price target$193.80$225.33

Year-by-year: BDX vs DRI ($10,000, DRIP)

YearBDX PortfolioBDX Income/yrDRI PortfolioDRI Income/yrGap
1← crossover$10,958$257.59$11,305$604.97$347.00DRI
2$12,024$299.40$13,375$1,278.36$1.4KDRI
3$13,214$348.50$17,138$2,826.91$3.9KDRI
4$14,545$406.26$25,108$6,770.65$10.6KDRI
5$16,038$474.35$45,407$18,541.07$29.4KDRI
6$17,715$554.80$111,259$62,674.02$93.5KDRI
7$19,606$650.06$406,092$287,044.64$386.5KDRI
8$21,741$763.12$2,392,840$1,958,321.72$2.37MDRI
9$24,161$897.64$24,128,817$21,568,477.53$24.10MDRI
10$26,910$1,058.14$432,343,561$406,525,727.38$432.32MDRI

BDX vs DRI: Complete Analysis 2026

BDXHealthcare

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.

Full BDX Calculator →

DRIConsumer Discretionary

Darden Restaurants, Inc., through its subsidiaries, owns and operates full-service restaurants in the United States and Canada. As of May 29, 2022, it owned and operated 1,867 restaurants, which included 884 under the Olive Garden brand, 546 under the LongHorn Steakhouse brand name, 172 under the Cheddar's Scratch Kitchen brand, 85 under the Yard House brand name, 62 under The Capital Grille brand, 45 under the Seasons 52 brand name, 42 under the Bahama Breeze brand, 28 under the Eddie V's Prime Seafood brand name, and 3 under the Capital Burger brand; and franchised 60 restaurants comprising 35 under the Olive Garden brand, 18 under the LongHorn Steakhouse brand name, 4 under the Cheddar's Scratch Kitchen brand, 2 under The Capital Grille brand name, and 1 under the Bahama Breeze brand.Darden Restaurants, Inc. was founded in 1968 and is based in Orlando, Florida.

Full DRI Calculator →
📬

Get this BDX vs DRI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BDX vs SCHDBDX vs JEPIBDX vs OBDX vs KOBDX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.